# BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction

> **NCT01569178** · PHASE3 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 375 (actual)

## Conditions studied

- Myocardial Infarction
- Death

## Interventions

- **PROCEDURE:** Bone Marrow aspiration and intracoronary reinfusion

## Key facts

- **NCT ID:** NCT01569178
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2019-11-27
- **Final completion:** 2019-11-27
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01569178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01569178, "BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01569178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*